Skip to content

Medical device and MedTech insights, news, tips and more

Bariatric Surgery Safe, Effective for Lower-BMI Patients With Diabetes 

February 26, 2016

Bariatric Surgery

Los Angeles—It’s been a decades-long effort to have bariatric surgery accepted as a safe, effective treatment for people who are morbidly obese.

Now, a new study presented at ObesityWeek 2015 suggests that bariatric procedures also should be considered a safe, effective treatment for people who have type 2 diabetes and are overweight or mildly obese.Bariatric Surgery

“A two-hour operation and a two-day hospital stay has the potential to resolve or improve what is a chronic, progressive and dangerous disease,” said John M. Morton, MD, immediate past president of the American Society for Metabolic and Bariatric Surgery, and chief of bariatric and minimally invasive surgery at Stanford University School of Medicine, in California, who was not involved in the study.

“The risk–benefit profile that has emerged for bariatric surgery in people with type 2 diabetes and low body mass index [BMI] is very favorable and should be considered as a treatment option in carefully selected patients.”

The Cleveland Clinic researchers who conducted the study say it is the largest published series of bariatric surgery in patients with type 2 diabetes and a BMI of 35 kg/m2 or less.

They evaluated 1,003 patients from North America with a BMI between 25 and 35 kg/m2. The average BMI in the study cohort was 33.5 kg/m2. Forty percent of patients were taking insulin injections and 60% were on oral medications for their diabetes before surgery.

Analysis showed that bariatric surgery was associated with a low rate of complications and mortality in these lower BMI patients. The 30-day postoperative mortality rate was 0.2% and the cumulative rate of postoperative adverse events was 4%; 1.6% of patients required reoperation within 30 days. The procedures averaged 110 minutes, and patients were discharged from the hospital within two days.

“We are seeing significant improvement or remission of type 2 diabetes in most lower-BMI patients,” said lead investigator Ali Aminian, MD, laparoscopic and bariatric surgeon at the Cleveland Clinic Digestive Disease Institute, in Ohio. “Currently, evidence suggests that baseline BMI is unrelated to diabetes remission following bariatric and metabolic surgery.

Source: Bariatric Surgery Safe, Effective for Lower-BMI Patients With Diabetes – General Surgery News

By Christina Frangou

More insights

March 7, 2024
FDA Clears Dexcom’s First Over-the-Counter Continuous Glucose Monitor
Learn More
March 1, 2024
FDA greenlights Boston Scientific’s Novel Drug-Coated Balloon for Coronary In-Stent Restenosis
Learn More
February 21, 2024
Sparrow BioAcoustics Launches Software That Turns a Smartphone into a Stethoscope 
Learn More

Begin your legacy now. We are your medtech and medical device talent advisory firm.